Home / Netherlands / Aperam S.A.
Aperam S.A.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
711 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
November 1, 2012 today
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Aperam S.A. by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 30, 2013 | Adage Capital Management L.P. | 3.11% | |
| January 29, 2013 | Adage Capital Management L.P. | 3.08% | |
| January 25, 2013 | UBS O'Connor Limited | 0.48% | |
| January 22, 2013 | Adage Capital Management L.P. | 2.70% | |
| January 21, 2013 | Adage Capital Management L.P. | 2.25% | |
| January 21, 2013 | UBS O'Connor Limited | 0.52% | |
| January 17, 2013 | Adage Capital Management L.P. | 2.12% | |
| January 8, 2013 | Bocage Capital, LLC | 0.44% | |
| December 5, 2012 | Bocage Capital, LLC | 0.70% | |
| November 19, 2012 | TT International | 0.47% | |
| November 1, 2012 | TT International | 0.52% |
Download 711 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the Netherlands
- Akzo Nobel N.V. 9.76% of the capital sold short
- Pharming Group N.V. 7.88% of the capital sold short
- Signify N.V. 7.52% of the capital sold short
- Imcd N.V. 4.65% of the capital sold short
- Fugro N.V. 4.20% of the capital sold short
- DSM-Firmenich AG 3.48% of the capital sold short
- Basic-Fit N.V. 3.43% of the capital sold short
- PostNL N.V. 2.55% of the capital sold short
- NSI N.V. 2.01% of the capital sold short
- Alfen N.V. 1.85% of the capital sold short
- Arcadis N.V. 1.72% of the capital sold short
- TomTom N.V. 1.71% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Aperam S.A., source AFM, data as at March 11, 2026, https://www.quivad.com/action/aperam-s-a?page=15